HIV Seroprevalence Among Pregnant Women Attending Ante- Natal Clinic in a Tertiary Health Institution in Benin City, Nigeria

Imade, Paul Erhunmwunse; Ibadin, Kennedy; Eghafona, N. O.; Enabulele, Onaiwu Idahosa; Ophori, E. A.

doi:10.3889/mjms.1857-5773.2010.0090

Cited by 12 publications

(21 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Nigeria, the prevalence of HIV gradually increased from 1.8% in 1991 to 4.1% in 2010 (NACA 2012). The 5.6% prevalence in this study is comparable to reports of 5.2% in Benin City (Imade et al, 2010), 5.4% in Abakaliki (Obi, 2005), 5.93% in Port -Harcourt (Obi et al, 2007) all in Nigeria and 6.2% in Addis Ababa (Mirkuzies et al, 2010) but lower than 8.2% in Jos (Obi et al, 2007) and 10.5% in Nnewi (Akabuike et al, 2010) in Nigeria. The variations may be a reflection of the differences in sexual practices and behaviour, awareness of HIV infection and testing, socio-cultural practices and accessibility to healthcare.…”

Section: Discussionsupporting

confidence: 80%

Pregnancy Outcomes in Booked HIV Positive Women Initiating Highly Active Antiretroviral Therapy

Adeniran¹,

Afolabi²,

Saidu³

2014

J. Med. Biomed. Sci.

View full text Add to dashboard Cite

Pregnancy outcomes in HIV positive women remain a concern especially in sub-Saharan Africa which bears the highest burden of the disease. To evaluate pregnancy outcomes in booked pregnant women on Highly Active Antiretroviral Therapy (HAART) at the University of Ilorin Teaching Hospital (UITH), Ilorin, Nigeria; a case control study (with women initiating HAART in pregnancy as subjects and those who initiated it before pregnancy as control) of 268 HIV-positive women managed between March 2009 and February 2013 was undertaken at the hospital. Inclusion criteria comprised HIV-positivity, booking, antenatal care and delivery at the study site. From the total of 8,958 women who had antenatal care during the period, 502 had HIV infection (prevalence 5.6%) out of which 268 satisfied the inclusion criteria and were enrolled into the study. Subjects were 54(20.2%) while 214(79.8%) were controls; the mean age of participants was 31.0±4.5 years while mean parity was 2.0±1.5. Pregnancy outcomes were worse in subjects with statistical significance in miscarriage (11.1% vs. 0.9%; OR 11.78, 95% CI 2.07-87.03, p <0.01), preterm delivery (31.5% vs. 1.9%; OR 24.35, 95% CI 7.15-91.26, p<0.01), term pregnancy (42.6% vs. 96.3%; OR 0.03, 95% CI 0.01-0.08, p<0.01), birth asphyxia (OR 8.31, 95% CI 3.25-21.45 p<0.01), low birth weight babies (OR 260.0, 95% CI 66.51-1142.77, p<0.01) and maternal puerperal complications (anaemia 35.2% vs. 0. 9%; OR 68.79, 95% CI 14.28-452.19, p <0.01). Mother to child transmission of HIV was recorded in only 3(1.1%) babies among the subjects. Commencement of HAART before pregnancy appears to improve pregnancy outcomes in HIV positive women.

show abstract

Section: Discussionsupporting

confidence: 80%

Pregnancy Outcomes in Booked HIV Positive Women Initiating Highly Active Antiretroviral Therapy

Adeniran¹,

Afolabi²,

Saidu³

2014

J. Med. Biomed. Sci.

View full text Add to dashboard Cite

show abstract

“…Sagay et al, in a study done in Jos, Nigeria using pregnant women reported that women aged 20-29 years had more than 4 fold increased risk of HIV, the prevalence of HIV increased from 2.2% among women below 20 years of age to 10.9% in subjects aged 25-29 years, and then reduced to 1.9% women aged 40 years and above (28). Imade et al ., in a study done using pregnant women attending the University hospital in Benin City, Nigeria observed that younger pregnant women were more likely infected with HIV than the older ones (17). In that study, the age groups 15-20 to 31-35 had a higher prevalence of HIV though it was not statistically significant.…”

Section: Discussionmentioning

confidence: 74%

“…Previous Studies carried out evaluating the prevalence of HIV in pregnant women in Nigeria has focused on urban settings, with little or no studies done in rural areas (17,18). No study has been conducted in these communities on the HIV/ HBV, HIV/HCV and HIV/HCV/HBV co-infection.…”

Section: Introductionmentioning

confidence: 99%

Sero-Epidemiology of Human Immunodeficency Virus, Hepatitis B and C among Pregnant Women in Rural Communities of Abaji Area Council, Nigeria

Osazuwa¹

2012

TAF Prev Med Bull

View full text Add to dashboard Cite

AIM: Human immunodeficiency virus (HIV) infection continues to be a major public health problem worldwide and most especially in sub Saharan Africa .It has been reported that the highest burden of HIV is located in this region. HIV is particularly significant in their ability of transferred from mother to their newborn. Hepatitis B (HBV) and hepatitis C (HCV) is recently been recognized also as a cause of mortality and morbidity in pregnant women in many obstetric centers worldwide. In view of the deleterious nature of these infections and paucity of reports on their prevalence among pregnant women attending antenatal clinics in rural settings in Nigeria, This study thus aimed to evaluate using serological techniques, the prevalence of HIV, HBV and anti-HCV antibodies among pregnant women attending the General Hospital, Abaji from various rural communities of Abaji local Area Council, of the federal capital city, Nigeria. METHOD: The study was a hospital based cross-sectional survey including 395 pregnant women attending the antenatal clinic of the General Hospital, Abaji, from 1st April 2010- 30th March 2011. Questionnaires administered by a nursing staff were used to gather information on bio-data, socio-economic and demographic status. Rapid diagnostic test kits were used to screen for HIV, HBV and anti-HCV antibodies. Statistical analysis was carried out using the SPSS software version 16. RESULTS: 23(5.8%), 45 (11.4%) and 12 (3.0%) out of 395 pregnant women included in the study were found to be positive for Serum antibodies to HIV, HBV and HCV respectively. The age group 22-26 was the most infected and showed highest seropositivity to all serological markers. History of sexually transmitted diseases (STI) (p<0.001) and multiple sexual partners (p=0.01) were significant factor in the acquisition of HIV. While Tattooing and multiple sexual partners proved statistically to play a role in seropositivity to HBV (p=0.01, p<0.001). None of the studied risk factors (Tattooing, History off blood transfusion, v ‘multiple sexual partners, educational status, history of STI, dental maneuvers and traditional scares) had a significant association on HCV seropositivity. CONCLUSION: The study presents the situation of HIV, HBV and HCV in the rural communities studied. It was observed that there exists a high prevalence of these viral infections amongst pregnant women in the communities studied. There is an urgent need to stem the growing prevalence of these infections in these rural communities, which is presently in a manageable state by proper and mandatory screening for these infections. [TAF Prev Med Bull 2012; 11(4.000): 431-438

show abstract

“…Contrary results were obtained by some investigators who conducted study on pregnant women in Nigeria. 15 They found that incidence of HIV infection is significantly higher in high income group because affluent attract a lot of social activity which may lead to reckless sexual activities especially among husbands who in turn pass infection to their wives.…”

Section: Discussionmentioning

confidence: 99%

Seroprevalence of human immunodeficiency virus and various risk factors responsible for spread of human immunodeficiency virus in pregnant women in Jammu, India

Kour

Gupta

Khajuria

2016

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

HIV Seroprevalence Among Pregnant Women Attending Ante- Natal Clinic in a Tertiary Health Institution in Benin City, Nigeria

Cited by 12 publications

References 6 publications

Pregnancy Outcomes in Booked HIV Positive Women Initiating Highly Active Antiretroviral Therapy

Pregnancy Outcomes in Booked HIV Positive Women Initiating Highly Active Antiretroviral Therapy

Sero-Epidemiology of Human Immunodeficency Virus, Hepatitis B and C among Pregnant Women in Rural Communities of Abaji Area Council, Nigeria

Seroprevalence of human immunodeficiency virus and various risk factors responsible for spread of human immunodeficiency virus in pregnant women in Jammu, India

Contact Info

Product

Resources

About